| Identification | Back Directory | [Name]
1-Piperazinecarboxamide, 4-[5-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]pentyl]-N-[4-[[[5-[[(1S)-1-(hydroxymethyl)propyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]methyl]phenyl]- | [CAS]
2411021-01-5 | [Synonyms]
PROTAC CDK9 degrader-4
4-{5-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-4-yl]pentyl}-N-(4-{[(5-{[(2S)-1-hydroxybutan-2-yl]amino}-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino]methyl}phenyl)piperazine-1-carboxamide
1-Piperazinecarboxamide, 4-[5-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]pentyl]-N-[4-[[[5-[[(1S)-1-(hydroxymethyl)propyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]methyl]phenyl]- | [Molecular Formula]
C43H56N10O5 | [MOL File]
2411021-01-5.mol | [Molecular Weight]
792.97 |
| Hazard Information | Back Directory | [Uses]
PROTAC CDK9 degrader-4 is a highly potent and efficacious CDK9 degrader for targeting transcription regulation. | [References]
[1] Wei D, et al. Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer. J Med Chem. 2021 Oct 14;64(19):14822-14847. DOI:10.1021/acs.jmedchem.1c01350 |
|
|